Search for: "In re J. C."
Results 61 - 80
of 4,357
Sort by Relevance
|
Sort by Date
24 Apr 2024, 11:27 am
”[10] Fourth, the plaintiffs’ claims were before Chief Judge Nancy J. [read post]
23 Apr 2024, 10:56 am
C. 1229, which is now burned into my memory forever. [read post]
22 Apr 2024, 2:04 pm
Stafford, 226 F.3d 275 (3d Cir. 2000); In re NVIDIA Sec. [read post]
22 Apr 2024, 10:01 am
Donald J. [read post]
22 Apr 2024, 5:00 am
Trump (SDNY), YALE J. [read post]
22 Apr 2024, 1:06 am
In his criminal trial, which was aborted and not re-tried due to concerns about the Lehrmann’s mental health, the former Staffer had pleaded not guilty. [read post]
20 Apr 2024, 6:37 pm
U.S. [read post]
19 Apr 2024, 9:27 am
Additionally, we’re pleased to welcome Afruz Sayah as an Associate and Stephanie Cepeda as a Paralegal for the Corporate and Transactional practice group. [read post]
18 Apr 2024, 9:01 pm
But irrespective of the context, if you’re speaking on AI, you too must ensure that you do so in a manner that is not materially false or misleading. [read post]
17 Apr 2024, 11:27 pm
In considering the criteria, Jackman J noted the Court must take into account the ‘transparency’ of the term, per s 12BG(2)(b), in addition to the contract as a whole, per s 12BG(2)(c), in interpreting unfairness. [read post]
17 Apr 2024, 8:59 am
From N.C. [read post]
15 Apr 2024, 6:00 pm
They're targeting single-judge divisions. [read post]
14 Apr 2024, 4:00 am
Intitulé : R. c. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
11 Apr 2024, 3:00 am
” A person enjoys a sunny day at César Chávez Park in 2017. [read post]
8 Apr 2024, 10:08 am
As a practical matter, the burden shifts to the party that wishes to challenge the relied upon facts and data to learn more about the cited studies to show that the facts and data are not sufficient under Rule 702(b), and that the testimony is not the product of reliable methods under Rule 702(c). [read post]
8 Apr 2024, 5:32 am
Defense attorney Anne C. [read post]
3 Apr 2024, 9:33 pm
(Check for commentary on CanLII Connects) Planigestec inc. c. [read post]
3 Apr 2024, 4:08 pm
Re-analyses can be important, but these reanalyses of published Bendectin studies were post hoc, litigation driven, and obviously result oriented. [read post]
2 Apr 2024, 4:50 am
c) Must a claim to a single chemical compound make it plausible that the compound is useful for a particular purpose? [read post]
